ASK REDCHAT ANYTHING ABOUT MONTE ROSA THERAPEUTICS INC.
Monte Rosa Therapeutics Inc. (NASDAQ: GLUE)
Listen to this Section
$23.02
-0.0200
(
-0.09% )
4.4K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| MRT-6160DetailsInflammatory disease, Autoimmune disease, Neurological disorder |
Phase 1 |
| MRT-2359DetailsSolid tumor/s, Non-small cell lung carcinoma |
Phase 1 |
Market Data
|
| Open |
$23.02 |
| Previous Close |
$23.04 |
| Volume |
4.4K |
| Market Cap |
$1.95B |
| Day Range |
$22.52 - $24.77 |
| 52 Week Range |
$4.12 - $25.77 |
| Shares Outstanding |
84.48M |
| Change % |
-0.09% |
| Net Change |
▼ -0.0200 |
| Insider Ownership |
-0.19% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | J.P. Morgan, TD Cowen, Piper Sandler, Guggenheim Securities, more |
Insider Ownership Transactions
Total Amount Purchased:
-1,054,417.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-07-09 |
Sale |
-1610.00 |
Dunn Edmund |
| 2024-06-13 |
Sale |
-22100.00 |
Behbahani Ali |
| 2024-06-13 |
Sale |
-22100.00 |
Siu Christine |
| 2024-06-13 |
Sale |
-22100.00 |
SCHIFF ANDREW N |
| 2024-06-13 |
Sale |
-22100.00 |
Skvarka Jan |
| 2024-06-13 |
Sale |
-22100.00 |
Manning Anthony M. |
| 2024-06-13 |
Sale |
-22100.00 |
Blackwell Kimberly |
| 2024-06-05 |
Sale |
-1207.00 |
Dunn Edmund |
| 2024-06-05 |
Sale |
-40000.00 |
Nickson Philip |
| 2024-06-05 |
Sale |
-40000.00 |
Townson Sharon |